Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

HMR describes new NCBE inhibitor series for cardiovascular disorders

April 29, 1999

Pyrazoles acting as modulators of cGMP production disclosed by Hoechst Marion Roussel

April 29, 1999

TMR plus CABG offers positive clinical results

April 29, 1999

Genzyme explores cell therapy for cardiovascular disease

April 29, 1999

NDA for Natrecor not approved by FDA

April 28, 1999

Inhibitors of NOS described by Pfizer

April 28, 1999

LXR Biotechnology receives disappointing preliminary preclinical results with Elirex

April 28, 1999

Dual-action antiatherosclerotic agents in the Sankyo pipeline

April 27, 1999

China Pharmaceutical University develops effective antiarrhythmic agents

April 27, 1999

Vasodilating benzamide and cinnamide derivatives from China

April 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...